期刊文献+

RNA干扰抑制胰岛素样生长因子-1表达并诱导胶质瘤细胞凋亡 被引量:2

Inhibition of insulin-like growth factor 1 expression in glioma cells apoptosis with RNA interference
下载PDF
导出
摘要 目的研究RNA干扰效应对胶质瘤C_6细胞株胰岛素样生长因子-1(IGF-1)基因表达的抑制作用及其对C_6细胞凋亡诱导的作用。方法体外化学合成靶向IGF-1基因的小干扰RNA(siRNA),采用脂质体法将siRNA以不同浓度梯度转染C_6细胞株,设非特异的siRNA阳性对照组和未转染siRNA的阴性对照组;同时使用绿色荧光素标记的siRNA异硫氰酸荧光素(FITC)-siRNA转染细胞,于荧光显微镜下观察siRNA转染效率;逆转录聚合酶链反应(RT-PCR)半定量检测siRNA对IGF-1基因表达的抑制作用;流式细胞术检测siRNA诱导细胞凋亡作用。结果荧光显微镜下荧光素标记的siRNA转染组可见到细胞内清晰的绿色荧光,脂质体Oligo- fectamine^(TM)2000的转染效率可>95%;化学合成的siRNA明显抑制IGF-1 mRNA的表达,各特异性siRNA不同浓度转染组IGF-1 mRNA表达水平可下调约40%~70%,流式细胞术检测转染IGF1-siRNA细胞凋亡率为14.14%,明显高于对照组的0.95%。结论在细胞水平上,化学合成的靶向IGF-1的siRNA可明显抑制IGF-1基因的表达,引致胶质瘤细胞凋亡率明显上升,为进一步利用RNA干扰进行胶质瘤的基因治疗研究奠定基础。 Objective To investigate the inhibitory effect of RNA interference on glioma insulin-like growth factor 1 (IGF-1) gene expression and induction of cell apoptosis. Methods Small interference RNAs (siRNAs) targeting IGF1 gene were synthesized chemically in vitro. C6 cells stably expressing IGF-1 gene were transfected with the siRNA using oligofectamineTM 2000 reagent. Both the nontransfected cells and nonspecific siRNAs transfected cells were taken as negative and positive controls, siRNA transfection efficiency was detected by fluorescent microscopy; down regulation of IGF-1 was demonstrated by RTPCR. Apoptosis of C6 cell was measured by flow cytometry. Results Green fluorescence in the cells was seen clearly in FITC-siRNA transfected group under the fluorescent microscope; the transfection efficiency of oligofectamineTM 2000 was 〉95 %. The expression of IGF-1 mRNA was decreased by 40%-70% in the siRNAs transfected C6 cells with RT-PCR scan analysis as compared with that of the controls. Cell apoptosis could be induced from 0.95% in the control group to 14.14%o at 72 h after transfection. Conclusions At the cellular level, the chemically synthesized siRNAs targeted IGF-1 gene can downregulate the expression of IGF-1, with a remarkable induced apoptosis in comparing with the control cell line. The finding provides a new horizon for the study of glioma gene therapy.
出处 《上海医学》 CAS CSCD 北大核心 2006年第8期557-560,F0003,共5页 Shanghai Medical Journal
基金 国家自然科学基金(30371459) 上海市科学技术发展基金项目(034047)资助项目
关键词 小干扰RNA 胰岛素样生长因子-1 胶质瘤 转染效率 !Small interference RNA Insulin-like growth factor 1 Glioma Transfection ratio
  • 相关文献

参考文献9

  • 1Favoni RE,de Cupis A,Ravera F,et al.Expression and function of the insulin-like growth factor I system in human non small-cell lung cancer and normal lung cell lines.Int J Cancer,1994,56:858-866.
  • 2Sui G,Soohoo C,Affar el B,et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proc Natl Acad Sci USA,2002,99:5515-5520.
  • 3Elbashir SM,Harborth J,Weber K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs.Methods,2002,26:199-213.
  • 4Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
  • 5MiyagishiM,Sumimoto H,Miyoshi H,et al.Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.J Gene Med,2004,6:715-723.
  • 6卢小东,覃文新,潘东宁,李锦军,万大方,温传俊,李朝军,顾健人,杨胜利.DNA载体途径的RNA干扰技术对肝癌细胞系HCCLM3端粒酶活性的抑制作用[J].中华医学杂志,2004,84(16):1381-1385. 被引量:11
  • 7Yu JY,Taylor J,DeRuiter SL,et al.Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors.Mol Ther,2003,7:228-236.
  • 8Wilda M,Fuchs U,Wssmann W,et al.Killing leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).Oncogene,2002,21:5716-5724.
  • 9Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21nucleotide RNAs mediate RNA interference in cultured mam malian cells.Nature,2001,411:494-498.

二级参考文献16

  • 1Kirkpatrick KL, Mokbel K. The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol, 2001,27:754-760.
  • 2Mergny JL, Riou JF, Mailliet P, et al. Natural and pharmacological regulation of telomerase. Nucleic Acids Res,2002,30:839-865.
  • 3Wang XW, Xiao JY, Zhao SP, et al. Expression of telomerase subumits and its relationship with telomerase activity in nasopharyngeal carcinoma. Natl Med J China,2001,81:553-556.王行炜,肖健云,赵素萍,等.鼻咽癌端粒酶各组分基
  • 4Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci, 2002, 99:5515-5520.
  • 5Perk NH, Guo W, Kim HR, et al. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter. Int J Oncol, 2001, 19:755-761.
  • 6Fujimoto K, Kyo S, Takakura M, et al. Identification and characterization of negative regulatory elements of the human telomerase catalytic aubunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res,200
  • 7Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1binding sites. J Virol, 2001, 75:5559-5566.
  • 8Hou M, Wang X, Popov N, et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res, 2002, 274:25-34.
  • 9Kosciolek BA, Kalantidis K, Tabler M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther, 2003, 2:209-216.
  • 10Kang SS, Kwon T, Kwon DY, et al. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. Biol Chem, 1999, 274:13085-13090.

共引文献10

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部